BigHat Biosciences
Latest round
- Series C
Last raised
- Sep 2026
Total raised
- $179M
Investors
- 20
About BigHat Biosciences
BigHat Biosciences, Inc.Founded in 2019 and headquartered in San Mateo, US, BigHat Biosciences specializes in revolutionizing antibody therapy design.BigHat Biosciences specializes in the design and development of antibody therapies utilizing its proprietary Milliner platform, which integrates synthetic biology and advanced machine learning technologies. This full-stack platform enables the rapid synthesis, purification, and characterization of hundreds of recombinant antibodies, targeting a range of challenging diseases, including various cancers and infectious diseases. By leveraging high-speed wet lab capabilities alongside machine learning, BigHat aims to create next-generation therapies that provide enhanced safety and efficacy through rational molecular design.BigHat Biosciences generates revenue through strategic partnerships and collaborations with leading pharmaceutical companies to advance the development of its therapeutic programs. These partnerships involve the sharing of resources and expertise, often structured around milestone payments and licensing agreements for proprietary technology and products. Clients benefit from BigHat’s innovative antibody engineering solutions, which streamline the drug discovery process. The business operates primarily on a B2B model, focusing on delivering tailored solutions for pharmaceutical partners seeking to enhance their therapeutic pipelines.
Who invested in BigHat Biosciences
20 investors across 4 rounds
See all investors in BigHat Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BigHat Biosciences
Who invested in BigHat Biosciences?
BigHat Biosciences has 20 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BigHat Biosciences raised?
BigHat Biosciences has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did BigHat Biosciences last raise money?
BigHat Biosciences's most recent round on record is a Series C, in Sep 2026.
What does BigHat Biosciences do?
BigHat Biosciences is a healthcare it company.
Where is BigHat Biosciences headquartered?
BigHat Biosciences is headquartered in San Mateo, US.
Which VCs invest in companies like BigHat Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back healthcare it companies at BigHat Biosciences's stage. Their profiles are linked below.
VCs backing healthcare it startups at Series C
Raising like BigHat Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.